This is a general alert to some recent articles. Subscribe from the link to the right to get an email as alerts are published.
Want an alert that is more targeted to your specific needs? Please submit a Subject alert request.
Featured
About this alert - Health technology assessment
09/06/2023
Library Service
No Subjects
No Subjects
09/03/2025
Building Lay Society Knowledge and Education for Health Technology Assessment and Policy Engagement: Case of CFTR Modulator Access in Brazil Healthcare (Basel). 2025;13(16)
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40868613
Choosing to Implement Value-Based Healthcare Initiatives: A Strategic Decision for Achieving Better Performance in Improving Population Health Comment on "Reflections on Managing the Performance of Value-Based Healthcare: A Scoping Review" Int J Health Policy Manag. 2025;14:9050
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40767201
Comprehensive analysis of frameworks for evaluating artificial intelligence solutions in Healthcare: A descriptive review Computers in Biology and Medicine. 2025;196(Pt B):110750
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40695025
Distributional cost-effectiveness analysis and health technology assessment at NICE: a response to Ramagopalan Value in Health. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40812750
Early-stage assessment of investigational digital technologies in mental health: a guide for innovators Psychiatry Research. 2025;351:116634
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40743859
Extensive digital health technology assessment detects subtle motor impairment in mild and asymptomatic Pompe disease Scientific Reports. 2025;15(1):29798
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40813881
FRAME: Framework for Real-World Evidence Assessment to Mitigate Evidence Uncertainties for Efficacy/Effectiveness - An Evaluation of Regulatory and Health Technology Assessment Decision Making Clinical Pharmacology and Therapeutics. 2025;118(3):649–661
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40493357
A Framework for Considering the Role of the Public Sector in R&D of Health Technology Pharmaceutical Medicine. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40779237
Health Technology Assessment of Continuous Glucose Monitoring Systems for Paediatric Patients Children (Basel). 2025;12(8)
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40868539
The Importance of a Methodological Manual for Economic Evaluations in Healthcare Decision-Making in Ecuador Pharmacoecon Open. 2025;9(5):713–722
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40450645
Including Productivity as an Element to Reflect Value of the Treatment: A Systematic Review of Published Health Economic Evaluations Pharmacoecon Open. 2025;9(5):723–738
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40553408
Methodological approaches in the economic evaluation of prognostic and predictive companion diagnostics: a systematic scoping review Expert Review of Pharmacoeconomics & Outcomes Research. 2025;25(7):1037–1049
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40518839
Patient Involvement in Health Technology Assessments: Lessons for EU Joint Clinical Assessments J Mark Access Health Policy. 2025;13(3):38
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40860957
Pivotal Studies for Drugs About to Be Launched for Rare Diseases: Will They Better Support Health Technology Assessment and Market Access than in the Past? J Mark Access Health Policy. 2025;13(3):37
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40860956
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 20 Journal of Comparative Effectiveness Research. 2025;14(9):e250113
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40698536
Selecting Cost-Effectiveness Methods for Health Benefits Package Design: A Systematic Approach Int J Health Policy Manag. 2025;14:8562
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40767209
A Systematic Review and Quality Assessment of Pharmacoeconomic Publications for China Compared to Internationally: Is the Quality of Evidence-Base Sufficient for Health Technology Assessment? Int J Health Policy Manag. 2025;14:8656
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40767195
Transportability of nonlocal real-world evidence and its relevance to health technology assessment: a primer Journal of Comparative Effectiveness Research. 2025:e250041
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40836909
Use of patient-reported outcome measures in cost-effectiveness models informing health technology assessments of non-oncology treatments: a review Journal of Medical Economics. 2025;28(1):1045–1060
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40635626
Value-Based Framework for Evaluating Pre-Commercial Procurement: Case Study of Value-Based Key Performance Indicators JMIR Form Res. 2025;9:e71279
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40811851
No Subjects
08/06/2025
The Acceptance of Overall Survival Extrapolation Methods in Solid Tumor Treatments by Health Technology Assessment Agencies in England, France, and Australia between 2017 and 2022 Medical Decision Making. 2025:272989x251351635
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40751431
Access in all areas? A round up of developments in market access and health technology assessment: part 8 Journal of Comparative Effectiveness Research. 2025;14(8):e250091
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40524671
Achieving Patient-Centered Value/Health Technology Assessment: Recommendations From a Multistakeholder eDelphi Panel Value in Health. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40633728
Applying early health technology assessment (e-HTA) to inform investment in novel health technologies in the US International Journal of Technology Assessment in Health Care. 2025;41(1):e45
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40625059
Are we properly evaluating genetic and genomic testing? A systematic review of health technology assessment reports Journal of Translational Medicine. 2025;23(1):749
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40624720
CAR-T cell therapies: patient access and affordability solutions Future Sci OA. 2025;11(1):2483613
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40156283
Cessation of smoking in people attending UK emergency departments: the COSTED RCT with economic and process evaluation Health Technology Assessment. 2025;29(35):1-36
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40748216
Challenges in Modelling the Cost Effectiveness of Pharmacotherapies for Obesity Pharmacoeconomics. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40717166
A Comprehensive View of the Methods Used to Measure the Societal Impact of Healthcare Interventions: A Systematic Review Value in Health. 2025;28(8):1288-1299
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40049328
Connecting minds and catalyzing collaboration: the interest groups of health technology assessment international International Journal of Technology Assessment in Health Care. 2025;41(1):e43
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40619817
Cost Comparisons in NICE Technology Appraisals: An External Assessment Group Perspective Pharmacoeconomics. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40699293
The Evolving Landscape of Discrete Choice Experiments in Health Economics: A Systematic Review Pharmacoeconomics. 2025;43(8):879-936
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40397369
Global research on patient involvement in health technology assessment: a bibliometric analysis Global Health Research and Policy. 2025;10(1):30
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40713904
Identification and Description of Regulatory and Health Technology Assessment Agencies' Guidance Related to Patient Experience Data in North America, Europe, and Asia Pacific Ther Innov Regul Sci. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40676467
Institutionalization of Health Technology Assessment of medical devices: a cluster analysis of EU, EEA, and EFTA countries International Journal of Technology Assessment in Health Care. 2025;41(1):e44
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40625064
Integrating Environmental Impact in Health Technology Assessment: An Exploratory Study Pharmacoeconomics. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40682640
Invasive urodynamic investigations in the management of women with refractory overactive bladder symptoms: FUTURE, a superiority RCT and economic evaluation Health Technology Assessment. 2025;29(27):1-139
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40620147
Navigating the future: horizon scanning and early dialogue in health technology assessment in Latin America International Journal of Technology Assessment in Health Care. 2025;41(1):e42
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40637451
Reflecting Social Values in HTA Methods: A Case Study of South Africa Applied Health Economics and Health Policy. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40660007
A systematic review of health economic evaluation quality assessment instruments for medical devices International Journal of Technology Assessment in Health Care. 2025;41(1):e40
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40638846
Towards the Operationalization of Health Technology Sustainability Assessment and the Early Eco Design of the Internet of Medical Things Sensors (Basel). 2025;25(13)
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40648098
Use of patient-reported outcome measures in cost-effectiveness models informing health technology assessments of non-oncology treatments: a review Journal of Medical Economics. 2025;28(1):1045-1060
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40635626
No Subjects
07/02/2025
Access in all areas? A round up of developments in market access and health technology assessment: part 8 Journal of Comparative Effectiveness Research. 2025:e250091
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40524671
Applications of artificial intelligence and the challenges in health technology assessment: a scoping review and framework with a focus on economic dimensions Health Econ Rev. 2025;15(1):46
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40461901
CAR-T cell therapies: patient access and affordability solutions Future Sci OA. 2025;11(1):2483613
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40156283
Clinical equivalence and non-inferiority within health technology assessment European Journal of Health Economics. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40506597
Defining Biological and Clinical Plausibility: The DICSA Framework for Protocolized Assessment in Survival Extrapolations Across Therapeutic Areas Pharmacoeconomics. 2025;43(7):793-803
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40156682
Defining early health technology assessment: building consensus using Delphi technique International Journal of Technology Assessment in Health Care. 2025;41(1):e34
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40452233
Defining early health technology assessment: reclaiming origins and diversity of applications International Journal of Technology Assessment in Health Care. 2025;41(1):e35
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40452383
Development and validation of a type 2 diabetes model to estimate the cost-effectiveness of diabetes interventions across the care continuum International Journal of Technology Assessment in Health Care. 2025;41(1):e36
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40452371
Evaluating Digital Health Solutions in Diabetes and the Role of Patient-Reported Outcomes: Targeted Literature Review JMIR Diabetes. 2025;10:e52909
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40466203
Exploring the Economic Burden of Pulmonary Arterial Hypertension and Its Relation to Disease Severity and Treatment Escalation: A Systematic Literature Review Pharmacoeconomics. 2025;43(7):741-760
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40244370
FRAME: Framework for Real-World Evidence Assessment to Mitigate Evidence Uncertainties for Efficacy/Effectiveness - An Evaluation of Regulatory and Health Technology Assessment Decision Making Clinical Pharmacology and Therapeutics. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40493357
Health Technology Assessment and Cardiology: A Review of the Present and Future of Innovation J Mark Access Health Policy. 2025;13(2):30
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40568382
Health Technology Assessment and Environmental Impact: A Scoping Review of State of Art and Future Perspective Applied Health Economics and Health Policy. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40549262
Including Productivity as an Element to Reflect Value of the Treatment: A Systematic Review of Published Health Economic Evaluations Pharmacoecon Open. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40553408
Methodological approaches in the economic evaluation of prognostic and predictive companion diagnostics: a systematic scoping review Expert Review of Pharmacoeconomics & Outcomes Research. 2025:1-13
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40518839
Patient Engagement and Patient Experience Data in Regulatory Review and Health Technology Assessment: Where Are We Today? Ther Innov Regul Sci. 2025;59(4):737-752
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40210822
Preparing future healthcare professionals for evidence-based decision-making using health technology assessment as an experiential learning tool Medical Teacher. 2025;47(7):1097-1099
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39663157
Quality in qualitative evidence: new best practice principles from NICE’s real-world evidence framework Journal of Comparative Effectiveness Research. 2025;14(7):e250064
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40511737
Quantifying the cost savings and health impacts of improving colonoscopy quality: an economic evaluation BMJ Qual Saf. 2025;34(7):469-478
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38925929
Rapid health technology assessment of galantamine for the treatment of Alzheimer’s disease: A review Medicine (Baltimore). 2025;104(23):e42744
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40489822
Selection and Prioritization of Medical Devices for HTA Evaluation: A Systematic Review of Existing Approaches Applied Health Economics and Health Policy. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40483311
Supporting translation with early health technology assessment: from definition to action International Journal of Technology Assessment in Health Care. 2025;41(1):e39
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40452623
No Subjects
06/04/2025
Access in all areas? A round up of developments in market access and health technology assessment: part 7 Journal of Comparative Effectiveness Research. 2025;14(6):e250043
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40223528
CAR-T cell therapies: patient access and affordability solutions Future Sci OA. 2025;11(1):2483613
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40156283
Challenges and reforms in Spain's health technology assessment system: analysis of criteria influencing medicines' reimbursement decisions between 2019 and 2022 in Spain European Journal of Health Economics. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40343653
Clinical and cost-effectiveness of detailed anomaly ultrasound screening in the first trimester: a mixed-methods study Health Technology Assessment. 2025;29(22):1-250
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40455571
Clinical and cost-effectiveness of lithium versus quetiapine augmentation for treatment-resistant depression in adults: LQD a pragmatic randomised controlled trial Health Technology Assessment. 2025;29(12):1-118
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40350798
Cost-utility analysis of the DREAMS START intervention for people living with dementia and their carers: a within-trial economic evaluation Lancet Healthy Longev. 2025;6(5):100708
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40412418
DEFINING EARLY HEALTH TECHNOLOGY ASSESSMENT: BUILDING CONSENSUS USING DELPHI TECHNIQUE International Journal of Technology Assessment in Health Care. 2025:1-27
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40452233
Early access to medicines with added therapeutic value: Measuring and comparing time to medicines access in England, France, Germany, Italy and Spain Health Policy. 2025;157:105317
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40300221
ESR Essentials: how to get to valuable radiology AI: the role of early health technology assessment-practice recommendations by the European Society of Medical Imaging Informatics European Radiology. 2025;35(6):3432-3441
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39636421
The Evolving Landscape of Discrete Choice Experiments in Health Economics: A Systematic Review Pharmacoeconomics. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40397369
The global landscape of country-level health technology assessment processes: A survey among 104 countries Health Policy Open. 2025;8:100138
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40236923
How similar is similar enough? Assessment of indirect treatment comparisons to support similarity for NICE's cost comparison route Value in Health. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40414457
The Importance of a Methodological Manual for Economic Evaluations in Healthcare Decision-Making in Ecuador Pharmacoecon Open. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40450645
Pricing combination products: not how but who? European Journal of Health Economics. 2025;26(4):537-540
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40244483
Rapid tests to inform triage and antibiotic prescribing decisions for adults presenting with suspected acute respiratory infection: a rapid evidence synthesis of clinical effectiveness and cost-utility studies Health Technology Assessment. 2025;29(13):1-114
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40380815
Redefining value assessment and healthcare funding priorities for medicines: the journey to patient-centric decision making in APAC - a systematic literature review International Journal of Technology Assessment in Health Care. 2025;41(1):e28
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40365699
Regional Citrate Anticoagulation Versus Systemic Heparin in Continuous Kidney Replacement Therapy: Examining the Role of Evidence in Health Technology Assessment Advances in Therapy. 2025;42(6):2606-2638
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40238058
Regulatory landscape of accelerated approval pathways for medical devices in the United States and the European Union Front Med Technol. 2025;7:1586070
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40444060
Software with artificial intelligence-derived algorithms for detecting and analysing lung nodules in CT scans: systematic review and economic evaluation Health Technology Assessment. 2025;29(14):1-234
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40380885
Stakeholders' Perspectives on Medication Adherence Enhancing Interventions Value in Health. 2025;28(5):676-679
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40340081
Strengthening the EU Health Technology Assessment Regulation: Integrating National Immunization Technical Advisory Groups for Comprehensive Vaccine Assessments J Mark Access Health Policy. 2025;13(2):16
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40276092
No Subjects
05/07/2025
CAR-T cell therapies: patient access and affordability solutions Future Sci OA. 2025;11(1):2483613
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40156283
Decision-Analytical Modelling of Medicines in the Middle East: A Systematic Review of Economic Evaluation Studies Applied Health Economics and Health Policy. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40221639
Different attitudes towards estimating indirect costs of disease: The example of cancer J Public Health Res. 2025;14(2):22799036251326636
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40296884
Early access to medicines with added therapeutic value: Measuring and comparing time to medicines access in England, France, Germany, Italy and Spain Health Policy. 2025;157:105317
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40300221
Examining Consistency Across NICE Single Technology Appraisals: A Review of Appraisals for Paroxysmal Nocturnal Haemoglobinuria Pharmacoeconomics. 2025;43(5):499-508
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39934600
Importance of Health Economics and Outcomes Research in the Product Lifecycle Pharmaceutical Medicine. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40227495
Is this test fit-for-purpose? Principles and a checklist for evaluating the clinical performance of a test in the new era of in vitro diagnostic (IVD) regulation Critical Reviews in Clinical Laboratory Sciences. 2025;62(3):182-197
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39912349
Learning strategies for laypeople to participate in health technology assessment: a scoping review International Journal of Technology Assessment in Health Care. 2025;41(1):e26
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40223508
Mapping methods gaps between EU joint clinical assessments and local health technology assessment decision-making: an environmental scan of guidance in select EU markets and harmonization challenges Journal of Comparative Effectiveness Research. 2025;14(5):e240240
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40008768
Matching-Adjusted Indirect Comparison Studies in Oncology: A Scoping Review Focused on Reporting Quality Value Health Reg Issues. 2025;47:101088
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39999561
The need to consider market access for pharmaceutical investment decisions: a primer Journal of Comparative Effectiveness Research. 2025;14(5):e250036
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40183520
Regional Citrate Anticoagulation Versus Systemic Heparin in Continuous Kidney Replacement Therapy: Examining the Role of Evidence in Health Technology Assessment Advances in Therapy. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40238058
The role and value of real-world evidence in health technology decision-making in France, Germany, Italy, Spain, and the UK: insights on external control arms International Journal of Technology Assessment in Health Care. 2025;41(1):e25
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40260460
Strengthening health technology assessment for cancer treatments in Europe by integrating causal inference and target trial emulation Lancet Reg Health Eur. 2025;52:101294
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40255411
A Systematic Review of Economic Evaluations in Clinical Nursing Practices Journal of Nursing Management. 2024;2024:9939254
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40224743
Using Real-World Evidence for Clinical Development to Address the Gap Between Marketing Authorisation and Reimbursement in European Countries: Insights From Literature Review Journal of Evaluation in Clinical Practice. 2025;31(3):e70090
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40189820
Utility Studies in Rare Diseases: A Systematic Literature Review Value in Health. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40220862
No Subjects
04/02/2025
Advancing Principled Pharmacoepidemiologic Research to Support Regulatory and Healthcare Decision Making: The Era of Real-World Evidence Clinical Pharmacology and Therapeutics. 2025;117(4):927-937
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39807817
"Blanket rules just don't work": Qualitative exploration of the relative value of child and adult Quality Adjusted Life Year (QALY) gains for health technology assessment International Journal of Technology Assessment in Health Care. 2025:1-34
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40151870
CAR-T cell therapies: patient access and affordability solutions Future Sci OA. 2025;11(1):2483613
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40156283
A Comprehensive View of the Methods Used to Measure the Societal Impact of Healthcare Interventions: A Systematic Review Value in Health. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40049328
Economic Evaluations of Treatment of Depressive Disorders in Adolescents: A Scoping Review Value in Health. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40049329
Enhancing systematic literature reviews with generative artificial intelligence: development, applications, and performance evaluation Journal of the American Medical Informatics Association. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40036547
Guidance for an Effective Approach to Integrated Evidence Planning in a Dynamic World Clinical Pharmacology and Therapeutics. 2025;117(4):920-926
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39789863
Harmonizing HTA Evidence Needs and Expectations: Challenges and Opportunities to Improve Evidence Generation, Ensure Access and Affordability Clinical Pharmacology and Therapeutics. 2025;117(4):938-945
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39972486
Harnessing health technology assessment in India: paving the way for sustainable healthcare solutions in developing countries BMJ Evidence Based Medicine. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40037703
Hospital admissions attributable to reduced air pollution due to clean-air policies in China Nature Medicine. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40087514
Is health technology assessment value for money? Estimating the return on investment of health technology assessment in India (HTAIn) BMJ Evidence Based Medicine. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40113231
Methods for the health technology assessment of complex interventions: A scoping review PloS One. 2025;20(3):e0315381
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40085544
Navigating barriers to health technology assessment development in Iran: a qualitative exploration of stakeholder perspectives Arch Public Health. 2025;83(1):83
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40148921
NAVIGATING CHANGE: A COMPARATIVE ANALYSIS OF HEALTH TECHNOLOGY ASSESSMENT REFORMS ACROSS AGENCIES - PROCESSES, DRIVERS, AND INTERDEPENDENCIES International Journal of Technology Assessment in Health Care. 2025:1-30
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40083319
New IPECAD Open-Source Model Framework for the Health Technology Assessment of Early Alzheimer's Disease Treatment: Development and Use Cases Value in Health. 2025;28(4):511-518
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39094686
PATIENT ENGAGEMENT FOR THE DEVELOPMENT OF EQUITY-FOCUSED HEALTH TECHNOLOGY ASSESSMENT (HTA) RECOMMENDATIONS: A CASE STUDY OF TWO CANADIAN HTA ORGANIZATIONS International Journal of Technology Assessment in Health Care. 2025:1-28
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40151855
Planning Post-Launch Evidence Generation: Lessons From France, England and Spain Clinical Pharmacology and Therapeutics. 2025;117(4):961-966
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39960266
The potential of the hospital-based Health Technology Assessment: Results of a world-wide survey International Journal of Technology Assessment in Health Care. 2025;41(1):e19
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40099540
PROBAST+AI: an updated quality, risk of bias, and applicability assessment tool for prediction models using regression or artificial intelligence methods BMJ. 2025;388:e082505
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40127903
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 18 Journal of Comparative Effectiveness Research. 2025;14(4):e250014
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39963965
Role of Health Equity in Health Technology Assessment Processes: A Landscape Analysis of 13 Health Systems in Asia Value in Health. 2025;28(4):582-590
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39922297
Selection of indirect treatment comparisons for health technology assessments: a practical guide for health economics and outcomes research scientists and clinicians BMJ Open. 2025;15(3):e091961
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40132816
Uncertainty in Matching-Adjusted Indirect Comparisons Using Real-World Evidence: Evidence Assessment Group Perspective Pharmacoeconomics. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40117115
Use of Real-World Evidence in Health Technology Reassessments Across Six Health Technology Assessment Agencies Value in Health. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40054770
Using natural experiments to evaluate population health and health system interventions: new framework for producers and users of evidence BMJ. 2025;388:e080505
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40154983
No Subjects
03/06/2025
AI for IMPACTS Framework for Evaluating the Long-Term Real-World Impacts of AI-Powered Clinician Tools: Systematic Review and Narrative Synthesis Journal of Medical Internet Research. 2025;27:e67485
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39909417
Biomarker-Guided Antibiotic Duration for Hospitalized Patients With Suspected Sepsis: The ADAPT-Sepsis Randomized Clinical Trial JAMA. 2025;333(8):682-693
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39652885
Clinical and cost-effectiveness of a home-based health promotion intervention for older people with mild frailty in England: a multicentre, parallel-group, randomised controlled trial Lancet Healthy Longev. 2025;6(2):100670
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40015296
Clinical trials for implantable neural prostheses: understanding the ethical and technical requirements Lancet Digit Health. 2025;7(3):e216-e224
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39794174
Economic Evaluation of Robotic-assisted Radical Prostatectomy: A Systematic Review and Meta-analysis Eur Urol Open Sci. 2025;72:17-28
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39996029
Enhancing systematic literature reviews with generative artificial intelligence: development, applications, and performance evaluation Journal of the American Medical Informatics Association. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40036547
ENIGMA-shock: protocol for a study framEwork for aN InteGrated assessMent of cArdiac rehabilitation programmes in patients acutely managed for cardiogenic shock BMJ Open. 2025;15(2):e092790
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39938955
Harnessing health technology assessment in India: paving the way for sustainable healthcare solutions in developing countries BMJ Evidence Based Medicine. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40037703
Is this test fit-for-purpose? Principles and a checklist for evaluating the clinical performance of a test in the new era of in vitro diagnostic (IVD) regulation Critical Reviews in Clinical Laboratory Sciences. 2025:1-16
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39912349
Mapping the Landscape of Open Source Health Economic Models: A Systematic Database Review and Analysis Value in Health. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39952464
Mentalisation-based treatment for antisocial personality disorder in males convicted of an offence on community probation in England and Wales (Mentalization for Offending Adult Males, MOAM): a multicentre, assessor-blinded, randomised controlled trial Lancet Psychiatry. 2025;12(3):208-219
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39978982
Methods and Practical Considerations for Conducting Budget Impact Analysis for Non-Pharmaceutical Interventions Applied Health Economics and Health Policy. 2025;23(2):197-208
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39820973
Patient-Informed Value Elements in Cost-Effectiveness Analyses of Major Depressive Disorder Treatment: A Literature Review and Synthesis Value in Health. 2025;28(3):399-405
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38852668
Prevalence of Immature Survival Data for Anticancer Drugs Presented to the National Institute for Health and Care Excellence Between 2018 and 2022 Value in Health. 2025;28(3):406-414
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39725010
Reporting of Patient and Public Involvement in Technology Appraisal and Assessment Reports: A Rapid Scoping Review Patient. 2025;18(2):109-114
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39487952
Systematic Literature Review of Access Pathways to Drugs for Patients with Rare Diseases Applied Health Economics and Health Policy. 2025;23(2):209-229
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39731657
Understanding "Alert Fatigue" in Primary Care: Qualitative Systematic Review of General Practitioners Attitudes and Experiences of Clinical Alerts, Prompts, and Reminders Journal of Medical Internet Research. 2025;27:e62763
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39918864
Understanding the effectiveness and underlying mechanisms of lifestyle modification interventions in adults with learning disabilities: a mixed-methods systematic review Health Technology Assessment. 2025;29(4):1-168
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40025754
Use of surrogate endpoints in health technology assessment: a review of selected NICE technology appraisals in oncology International Journal of Technology Assessment in Health Care. 2025;41(1):e11
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39967232
Uterine rupture following prostaglandins use in second trimester medical abortion: Fact or fiction? A systematic review International Journal of Gynaecology and Obstetrics. 2025;168(3):875-892
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39377762
Value and Implementation of Patient and Public Involvement and Engagement in Health Technology Assessment for Japan: implications from systematic searches International Journal of Technology Assessment in Health Care. 2025;41(1):e14
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40017112
No Subjects
02/05/2025
Annual versus less frequent mammographic surveillance in people with breast cancer aged 50 years and older in the UK (Mammo-50): a multicentre, randomised, phase 3, non-inferiority trial Lancet. 2025;405(10476):396-407
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39892911
Case for a health equity framework in health technology assessment Lancet. 2025;405(10476):376-377
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39892901
Celebrating 30 years of the international network of agencies for health technology assessment (INAHTA) International Journal of Technology Assessment in Health Care. 2025;41(1):e7
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39895096
Clinical trials for implantable neural prostheses: understanding the ethical and technical requirements Lancet Digit Health. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39794174
Comparison of health technology assessments for digital therapeutics in Germany, the United Kingdom and France Digit Health. 2025;11:20552076241308704
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39845519
Efficacy, safety and cost-effectiveness of obinutuzumab in patients with follicular lymphoma: a rapid review Frontiers in Pharmacology. 2024;15:1426772
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39830356
Evidence generation throughout paediatric medicines life cycle: findings from collaborative work between European Medicines Agency (EMA) and EUnetHTA on use of extrapolation British Journal of Pharmacology. 2025;182(3):484-494
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39574299
Financial challenges of being on long-term, high-cost medications Neurooncol Pract. 2025;12(Suppl 1):i49-i58
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39776525
Generative Artificial Intelligence for Health Technology Assessment: Opportunities, Challenges, and Policy Considerations: An ISPOR Working Group Report Value in Health. 2025;28(2):175-183
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39536966
Guidance for an Effective Approach to Integrated Evidence Planning in a Dynamic World Clinical Pharmacology and Therapeutics. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39789863
Hospital-based health technology assessment (HTA) in Latin America and the Caribbean: a scoping review Revista Panamericana de Salud Publica. 2025;49:e8
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39811043
How can actuarial science contribute to the field of health technology assessment? An interdisciplinary perspective International Journal of Technology Assessment in Health Care. 2025;41(1):e3
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39757736
MRI-assessed Dynamic Hyperinflation Induced by Tachypnea in Chronic Obstructive Pulmonary Disease: The SPIROMICS-HF Study Radiol Cardiothorac Imaging. 2025;7(1):e240053
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39836055
Multi-cancer early detection tests for general population screening: a systematic literature review Health Technology Assessment. 2025;29(2):1-105
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39898371
Multiple Perspectives on the Need for Real-World Evidence to Inform Regulatory and Health Technology Assessment Decision-Making: Scoping Review and Stakeholder Interviews Pharmacoepidemiology and Drug Safety. 2025;34(1):e70074
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39777765
The Paradigm Shift From Patient to Health Consumer: 20 Years of Value Assessment in Health Journal of Medical Internet Research. 2025;27:e60443
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39793021
Post-Market Evidence for Cancer Medicines in Regulatory and Clinical Decision-Making: A Scoping Review Pharmacoepidemiology and Drug Safety. 2025;34(1):e70093
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39805804
Revising EU pharmaceutical legislation: will it foster drug repurposing? Drug Discov Today. 2025;30(1):104286
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39756647
A Systematic Literature Review of Modelling Approaches to Evaluate the Cost Effectiveness of PET/CT for Therapy Response Monitoring in Oncology Pharmacoeconomics. 2025;43(2):133-151
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39488797
A systematic review of the cost-effectiveness of anti-VEGF drugs for the treatment of diabetic retinopathy Health Technology Assessment. 2025:1-19
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39881630
The Use of Real-World Data for Estimating Relative Treatment Effects in NICE Health Technology Assessment Submissions: A Review Pharmacoeconomics. 2025;43(2):123-131
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39520643
No Subjects
01/08/2025
Advancing cooperation in Health Technology Assessment in Europe: insights from the EUnetHTA 21 project amidst the evolving legal landscape of European HTA International Journal of Technology Assessment in Health Care. 2024;40(1):e75
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39663913
Artificial intelligence for breast cancer detection and its health technology assessment: A scoping review Computers in Biology and Medicine. 2025;184:109391
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39579663
Assessing Methods for Adjusting Estimates of Treatment Effectiveness for Patient Nonadherence in the Context of Time-to-Event Outcomes and Health Technology Assessment: A Simulation Study Medical Decision Making. 2025;45(1):60-73
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39520046
Building robust, proportionate, and timely approaches to regulation and evaluation of digital mental health technologies Lancet Digit Health. 2025;7(1):e89-e93
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39550311
Case studies of health economic analyses informing pharmaceutical health technology assessments for essential medicine selection and public-sector guidelines in South Africa International Journal of Technology Assessment in Health Care. 2024;40(1):e76
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39663916
Defining decision thresholds for judgments on health benefits and harms using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) Evidence to Decision (EtD) frameworks: a randomised methodological study (GRADE-THRESHOLD) Journal of Clinical Epidemiology. 2024:111639
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39662641
Economic burden of respiratory syncytial virus disease in Latin America: A systematic review Human Vaccines & Immunotherapeutics. 2024;20(1):2381298
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39082141
Evaluations of digital public health interventions in the WHO Southeast Asia Region: a systematic literature review International Journal of Technology Assessment in Health Care. 2024;40(1):e78
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39690747
Exploring adaptive health technology assessment for evaluating 10 cancer interventions: insights and lessons from a pilot study in India BMJ Evidence Based Medicine. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39746782
Food for thought: more explicit guidance for inclusion of caregiver perspectives in health technology assessment International Journal of Technology Assessment in Health Care. 2024;40(1):e77
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39663941
Generalized cost-effectiveness analysis: charting a path forward for measuring the societal value of medical technologies Journal of Comparative Effectiveness Research. 2025;14(1):e240213
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39589071
Good Practices for Health Technology Assessment Guideline Development: A Report of the Health Technology Assessment International, HTAsiaLink, and ISPOR Special Task Force International Journal of Technology Assessment in Health Care. 2025;40(1):e74
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39760423
Health technology assessment in the Brazilian National Health System: profile of CONITEC exclusion recommendations, 2012-2023 Epidemiol Serv Saude. 2024;33:e20240057
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39661821
Hospital-based health technology assessment of a screening rapid test MTBI (GFAP and UCH-L1 blood biomarkers) for mild traumatic brain injury International Journal of Technology Assessment in Health Care. 2024;41(1):e5
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39653609
How can actuarial science contribute to the field of health technology assessment? An interdisciplinary perspective International Journal of Technology Assessment in Health Care. 2025;41(1):e3
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39757736
How do we respond to the threat of multidrug-resistant bacteria? Comparison of antibiotic appraisals from 2016 to 2020 of the French, English, and German HTA agencies International Journal of Technology Assessment in Health Care. 2024;40(1):e72
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39651580
Improving antibiotic prescribing - Recommendations for funding and pricing policies to enhance use of point-of-care tests Health Policy Open. 2024;7:100129
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39430908
Incorporating Resource Constraints in Health Economic Evaluations: Overview and Methodological Considerations Pharmacoecon Open. 2024
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39688639
Involving Patients in Hospital-Based Health Technology Assessment of Innovative Medical Devices: Adapting to a Specific Local Context and Lessons Learned From the Assessment of an Ex Vivo Perfusion System of Human Donor Hearts Health Expectations. 2024;27(6):e70119
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39660693
Managing Pharmaceutical Costs in Health Systems: A Review of Affordability, Accessibility and Sustainability Strategies J Mark Access Health Policy. 2024;12(4):403-414
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39735247
Multi-indication Evidence Synthesis in Oncology Health Technology Assessment: Meta-analysis Methods and Their Application to a Case Study of Bevacizumab Medical Decision Making. 2025;45(1):17-33
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39555661
Preparing future healthcare professionals for evidence-based decision-making using health technology assessment as an experiential learning tool Medical Teacher. 2024:1-3
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39663157
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 17 Journal of Comparative Effectiveness Research. 2025;14(1):e240212
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39601215
Stakeholder perspectives on the current status and potential barriers of patient involvement in health technology assessment (HTA) across Europe International Journal of Technology Assessment in Health Care. 2024;40(1):e81
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39698996
Using Real-World Evidence for Health Technology Assessment in Asia: Suggested Typology and Scoping Review Value Health Reg Issues. 2024;46:101068
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39675183
No Subjects
12/04/2024
Advancing the role of real-world evidence in comparative effectiveness research Journal of Comparative Effectiveness Research. 2024;13(12):e240101
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39392412
Artificial intelligence for breast cancer detection and its health technology assessment: A scoping review Computers in Biology and Medicine. 2024;184:109391
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39579663
Building robust, proportionate, and timely approaches to regulation and evaluation of digital mental health technologies Lancet Digit Health. 2024
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39550311
Considerations for regulation and evaluation of digital mental health technologies Digit Health. 2024;10:20552076241293313
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39502489
Economic effects of priority setting in healthcare: a scoping review of current evidence BMJ Open. 2024;14(11):e086342
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39557552
Estimating hospitalization costs for Health Technology Appraisals (HTA) in England: a systematic literature review and best practice framework Journal of Medical Economics. 2024;27(1):1558-1568
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39558876
Ethical challenges for Health Technology Assessment (HTA) in the evolving evidence landscape International Journal of Technology Assessment in Health Care. 2024;40(1):e39
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39494823
A framework for improved collaboration on HTA in the Asia-Pacific region: a role for HTAsiaLink International Journal of Technology Assessment in Health Care. 2024;40(1):e43
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39494832
Generalized cost-effectiveness analysis: charting a path forward for measuring the societal value of medical technologies Journal of Comparative Effectiveness Research. 2024:e240213
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39589071
Health technology assessment framework for artificial intelligence-based technologies International Journal of Technology Assessment in Health Care. 2024;40(1):e61
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39568412
Health technology assessment in mental health services Ind Psychiatry J. 2024;33(Suppl 1):S246-s249
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39534133
Health technology assessment to support health benefits package design: a systematic review of economic evaluation evidence in Zambia BMC Health Services Research. 2024;24(1):1426
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39558344
Implementing a sandbox approach in health technology assessment: benefits and recommendations International Journal of Technology Assessment in Health Care. 2024;40(1):e44
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39494820
Incorporating healthcare access and equity in economic evaluations: a scoping review of guidelines International Journal of Technology Assessment in Health Care. 2024;40(1):e59
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39552285
Indirect Treatment Comparisons in Healthcare Decision Making: A Targeted Review of Regulatory Approval, Reimbursement, and Pricing Recommendations Globally for Oncology Drugs in 2021-2023 Advances in Therapy. 2024
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39531127
Is health technology assessment ready for generative pretrained transformer large language models? Report of a fishbowl inquiry International Journal of Technology Assessment in Health Care. 2024;40(1):e48
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39498482
Mapping frameworks for synthesizing qualitative evidence in health technology assessment International Journal of Technology Assessment in Health Care. 2024;40(1):e53
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39534917
Non-empirical methods for ethics research on digital technologies in medicine, health care and public health: a systematic journal review Medicine, Health Care, and Philosophy. 2024;27(4):513-528
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39120780
Nursing participation in health technology assessment: a pending issue? Revista Latino-Americana de Enfermagem. 2024;32:e4245
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39504073
The role of health economics within health technology assessment: past, present, and future - an Austrian perspective International Journal of Technology Assessment in Health Care. 2024;40(1):e51
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39498481
Systematic Review of Tools and Approaches for Evaluating the Transferability of Health Technology Assessments Across Different Jurisdictions Int J Health Policy Manag. 2024;13:8218
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39620521
The transition of assessing health technologies to social interventions in Sweden International Journal of Technology Assessment in Health Care. 2024;40(1):e66
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39610279
The Use of Real-World Data for Estimating Relative Treatment Effects in NICE Health Technology Assessment Submissions: A Review Pharmacoeconomics. 2024
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39520643
No Subjects